Cathie Wood's ARK Invest Stacks Up on Alibaba, Baidu, and Biotech Gems in Active Week
Share- Nishadil
- October 07, 2025
- 0 Comments
- 1 minutes read
- 1 Views

Cathie Wood's ARK Invest funds have once again made headlines with their strategic moves, as the innovative investment firm spent the week ending August 11, 2023, bolstering positions in key technology and biotechnology players. Keeping a close watch on disruptive innovation, ARK's latest transactions reveal a clear focus on the future of e-commerce, artificial intelligence, and genetic medicine.
Among the most notable additions were increased stakes in Chinese tech giants Alibaba (BABA) and Baidu (BIDU).
ARK's Fintech Innovation ETF (ARKF) and Next Generation Internet ETF (ARKW) collectively snapped up a significant 18,042 shares of Alibaba. This move underscores ARK's continued conviction in the e-commerce powerhouse, despite ongoing regulatory complexities in China. Not to be outdone, ARKW also expanded its holdings in search engine and AI leader Baidu, adding 8,000 shares, signaling a strong belief in its long-term growth trajectory in the burgeoning AI landscape.
The healthcare sector also saw considerable activity, particularly within the ARK Genomic Revolution ETF (ARKG).
The fund initiated new buys in Kodiak Sciences (KOD), adding 8,883 shares, and further invested in Intellia Therapeutics (NTLA) with an additional 4,000 shares. These purchases highlight ARK's consistent interest in companies at the forefront of genetic research and therapeutic development, aiming to capitalize on breakthroughs in areas like gene editing.
Conversely, ARK Invest made some strategic divestments during the week.
ARKG trimmed its position in CRISPR Therapeutics (CRSP) by selling 21,399 shares, a move that could reflect profit-taking or a reallocation of capital within its genomics portfolio. Additionally, a combined 11,280 shares of Exact Sciences (EXAS) were sold across both the flagship ARK Innovation ETF (ARKK) and ARKG, suggesting a re-evaluation of its weighting in the cancer diagnostics company.
These recent trades by Cathie Wood's ARK Invest continue to reflect their high-conviction, long-term investment philosophy focused on disruptive technologies.
Investors and market watchers will undoubtedly keep a keen eye on how these strategic allocations perform in the dynamic global markets.
.- Canada
- Health
- News
- HealthNews
- ArtificialIntelligence
- Shop
- Investing
- StockMarket
- Roku
- Biotechnology
- ECommerce
- Alibaba
- Baba
- Amzn
- Hon
- Ktos
- Lhx
- CathieWood
- ArkInvest
- Baidu
- Arkf
- Bidu
- Rblx
- Dkng
- Arkk
- Arkw
- Rbrk
- Arkq
- Arkg
- Arkx
- Kdk
- Ntla
- Jdlgf
- KodiakSciences
- IntelliaTherapeutics
- CrisprTherapeutics
- ExactSciences
- GenomicRevolution
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on